Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study.

Cleland JG, Taylor J, Freemantle N, Goode KM, Rigby AS, Tendera M.

Eur J Heart Fail. 2012 May;14(5):487-94. doi: 10.1093/eurjhf/hfs049. Epub 2012 Apr 14.

2.

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.

Anand IS, Rector TS, Cleland JG, Kuskowski M, McKelvie RS, Persson H, McMurray JJ, Zile MR, Komajda M, Massie BM, Carson PE.

Circ Heart Fail. 2011 Sep;4(5):569-77. doi: 10.1161/CIRCHEARTFAILURE.111.962654. Epub 2011 Jun 29.

3.

Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.

Carlsen CM, Bay M, Kirk V, Gøtze JP, Køber L, Nielsen OW.

Eur J Heart Fail. 2012 Mar;14(3):240-7. doi: 10.1093/eurjhf/hfs003. Epub 2012 Feb 7.

4.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
5.

N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).

Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP; TIME-CHF Investigators.

Eur J Heart Fail. 2013 Oct;15(10):1148-56. doi: 10.1093/eurjhf/hft076. Epub 2013 May 8.

6.

Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.

Januzzi JL Jr, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, Kim HN, Baggish AL, Weiner RB, Chen-Tournoux A, Marshall JE, Moore SA, Carlson WD, Lewis GD, Shin J, Sullivan D, Parks K, Wang TJ, Gregory SA, Uthamalingam S, Semigran MJ.

J Am Coll Cardiol. 2011 Oct 25;58(18):1881-9. doi: 10.1016/j.jacc.2011.03.072.

7.

Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death?

deFilippi CR, Christenson RH, Kop WJ, Gottdiener JS, Zhan M, Seliger SL.

J Am Coll Cardiol. 2011 Sep 27;58(14):1497-506. doi: 10.1016/j.jacc.2011.06.042.

8.

Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.

Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP; TIME-CHF Investigators.

Circ Heart Fail. 2014 Jan;7(1):131-9. doi: 10.1161/CIRCHEARTFAILURE.113.000527. Epub 2013 Dec 18.

10.

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.

Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.

N Engl J Med. 2005 Feb 17;352(7):666-75.

11.

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA.

Circulation. 2004 Sep 28;110(13):1780-6. Epub 2004 Sep 20.

12.

Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.

Kubler P, Jankowska EA, Majda J, Reczuch K, Banasiak W, Ponikowski P.

Int J Cardiol. 2008 Oct 13;129(3):373-8. Epub 2007 Dec 4.

PMID:
18054808
13.

[The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].

Tuğcu A, Yildirimtürk O, Aytekin S.

Turk Kardiyol Dern Ars. 2009 Mar;37(2):112-21. Turkish.

14.

Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.

Zuber M, Cuculi F, Attenhofer Jost CH, Kipfer P, Buser P, Seifert B, Erne P.

Scand Cardiovasc J. 2009;43(5):324-9. doi: 10.1080/14017430902769919.

PMID:
19247872
15.
16.

Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.

Dini FL, Whalley G, Poppe K, Fontanive P, Rosa GM, Doughty RN, Di Bello V.

Clin Cardiol. 2009 Dec;32(12):711-7. doi: 10.1002/clc.20617.

17.

[Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].

Manzano-Fernández S, Januzzi JL, Boronat García M, Bonaque-González JC, Muñoz-Esparza C, Albaladejo-Otón MD, Pastor-Pérez FJ, Pastor P, Valdés M, Pascual-Figal DA.

Rev Esp Cardiol. 2011 May;64(5):365-72. doi: 10.1016/j.recesp.2010.10.017. Epub 2011 Mar 11. Spanish.

18.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

19.
20.

Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.

Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ.

J Card Fail. 2000 Jun;6(2):130-9.

PMID:
10908087
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk